USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES?
Optimization of the pharmacotherapy in preoperative period is the cornerstone of the concept of risk modification of cardiovascular complications in the perioperative period. Therefore, special attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays conv...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2015-09-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/107 |
| _version_ | 1797232518311706624 |
|---|---|
| author | V. V. Samoylenko O. P. Shevchenko V. I. Burtsev |
| author_facet | V. V. Samoylenko O. P. Shevchenko V. I. Burtsev |
| author_sort | V. V. Samoylenko |
| collection | DOAJ |
| description | Optimization of the pharmacotherapy in preoperative period is the cornerstone of the concept of risk modification of cardiovascular complications in the perioperative period. Therefore, special attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays convincing evidence base for the use of this class of drugs in the perioperative period that was the basis for the development of clinical guidelines is accumulated. Moreover, results of large randomized trials of beta-blockers are controversial. This has resulted in significant differences in the classes of recommendations and levels of evidence.Analysis of the results of basic researches and the provisions of recommendations of the international and national professional medical societies on the use of beta-blockers in patients with cardiovascular disease to reduce the risk of cardiac complications in the perioperative period for planned extracardiac surgical procedures is presented. |
| first_indexed | 2024-03-08T14:06:57Z |
| format | Article |
| id | doaj.art-4ade0349f81041c4af2c58b8801ed559 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2024-04-24T16:01:33Z |
| publishDate | 2015-09-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-4ade0349f81041c4af2c58b8801ed5592024-04-01T07:43:21ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532015-09-019442042610.20996/1819-6446-2013-9-4-420-426106USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES?V. V. Samoylenko0O. P. Shevchenko1V. I. Burtsev2Russian National Research Medical University named after N.I. Pirogov, MoscowRussian National Research Medical University named after N.I. Pirogov, MoscowI.M. Setchenov First Moscow State Medical University, MoscowOptimization of the pharmacotherapy in preoperative period is the cornerstone of the concept of risk modification of cardiovascular complications in the perioperative period. Therefore, special attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays convincing evidence base for the use of this class of drugs in the perioperative period that was the basis for the development of clinical guidelines is accumulated. Moreover, results of large randomized trials of beta-blockers are controversial. This has resulted in significant differences in the classes of recommendations and levels of evidence.Analysis of the results of basic researches and the provisions of recommendations of the international and national professional medical societies on the use of beta-blockers in patients with cardiovascular disease to reduce the risk of cardiac complications in the perioperative period for planned extracardiac surgical procedures is presented.https://www.rpcardio.online/jour/article/view/107beta-blockerspostoperative periodcardiovascular complications |
| spellingShingle | V. V. Samoylenko O. P. Shevchenko V. I. Burtsev USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Рациональная фармакотерапия в кардиологии beta-blockers postoperative period cardiovascular complications |
| title | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? |
| title_full | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? |
| title_fullStr | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? |
| title_full_unstemmed | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? |
| title_short | USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? |
| title_sort | use of beta blockers in the perioperative period how strong are the evidences |
| topic | beta-blockers postoperative period cardiovascular complications |
| url | https://www.rpcardio.online/jour/article/view/107 |
| work_keys_str_mv | AT vvsamoylenko useofbetablockersintheperioperativeperiodhowstrongaretheevidences AT opshevchenko useofbetablockersintheperioperativeperiodhowstrongaretheevidences AT viburtsev useofbetablockersintheperioperativeperiodhowstrongaretheevidences |